Powered by EnsoSleep PPG, the new RPM offering enables clinicians to both test patients and monitor them longitudinally using a single PPG-based device
MADISON, WI – May 1, 2025 – EnsoData, an innovator in AI healthtech solutions, is proud to introduce a new RPM (remote physiological monitoring) offering to the EnsoSleep PPG ecosystem of AI tools. EnsoData’s RPM solution allows clinicians to seamlessly monitor patients over time and proactively intervene when patients need support with their therapy the most.
RPM creates a streamlined pathway from diagnostic testing to therapeutic monitoring. Using only a PPG-based device, EnsoSleep PPG Study Management, and the Celeste+ mobile application, RPM provides uniform AHI monitoring across all treatment modalities, including CPAP, implantable devices, oral appliances, and GLP-1s.
EnsoSleep PPG provides diagnostic-grade AHI data that monitors treatment response longitudinally as patients adjust to sleep apnea therapy to improve outcomes beyond 3- and 12-month milestones.
“EnsoData’s RPM solution uses the same device for monitoring therapy as for testing, making it very user friendly for both patients and our team. Our patients already understand the devices and the app from testing, so there’s no learning curve. Plus, our sleep staff can more easily track therapy progress, spot issues early, and provide timely support, all while accessing new billing codes to generate additional revenue beyond the testing phase,” said Dr. Ernesto Eusebio, Sleep & Apnea Institute of Florida.
Patients using EnsoData’s RPM solution are monitored at home using comfortable ring, watch, or patch based devices. As patients adjust to therapy, providers can perform at-home titrations. In-lab titrations often take weeks to schedule and require patients to sleep in an environment that is nonconducive to their typical night of sleep.
Sam Rusk, co-founder and Chief AI Officer, EnsoData, added: “The natural evolution for sleep care is in remote physiological monitoring from the home. Until now, sleep medicine lacked an RPM solution that combined comfortable, wireless devices and an easily accessible physician web portal. Turning AHI into a daily vital sign empowers clinicians to manage therapy proactively to improve patient outcomes.”
For more information about EnsoData’s RPM offering, visit www.ensodata.com
—
About EnsoData: EnsoData is a healthcare technology company that uses artificial intelligence (AI) and machine learning (ML) technology to connect sleep disorder diagnosis to therapy, simplifying and accelerating the sleep care pathway for both physicians and patients.
###
Media Contact:
Steven Miller
EnsoData
